Munich, Germany, March 27, 2014 – Sandoz announced today that Vasant (Vas) Narasimhan, MD, MPP, has been appointed Head of Sandoz Biopharmaceuticals & Oncology Injectables effective April 1, 2014. Vas, currently Global Head of Development at Novartis Vaccines, succeeds Ameet Mallik who will take on a new leadership role at Novartis Oncology. Vas will be responsible for biosimilars, oncology injectables, the biotechnology contract manufacturing business, as well as Sandoz’ industry-leading biosimilars pipeline.

“I am deeply grateful for Ameet’s outstanding …

  • Sandoz Filgrastim approved in all indications as the reference product
  • Sandoz becomes first company to secure approval for two biosimilars in Japan
  • Approval marks continued expansion of Sandoz’ biosimilar business

March 21, 2014 – Despite great progress made in the fight to eradicate Tuberculosis (TB), the disease remains a global killer and disproportionately affects the world’s poor. Sandoz, a leading provider of high-quality, affordable generic medicines, has the opportunity to significantly contribute to the fight against TB.

Tuberculosis (TB) is second only to HIV/AIDS as the greatest killer worldwide due to a single infectious agent, according to the World Health Organization. In 2012, 8.6 million people fell ill with TB and 1.3 million died from TB.

March 19, 2014 – The Sandoz Tuberculosis (TB) program is increasing its reach in Africa. Sandoz is expanding its Tuberculosis portfolio as well as its Corporate Responsibility initiatives to support positive health outcomes for more patients and ultimately, contribute towards the eradication of the disease.

Sandoz contributes to fighting Tuberculosis in Egypt

In Egypt, TB constitutes the second most important public health problem, after schistosomiasis. Although Egypt has relatively low levels of TB according to data from the World Health …

March 19, 2014 – The Sandoz Tuberculosis (TB) program is increasing its reach in Africa. Sandoz is expanding its Tuberculosis portfolio as well as its Corporate Responsibility initiatives to support positive health outcomes for more patients and ultimately, contribute towards the eradication of the disease.

Sandoz contributes to fighting Tuberculosis in Egypt

In Egypt, TB constitutes the second most important public health problem, after schistosomiasis. Although Egypt has relatively low levels of TB according to data from the World Health …

Munich, Germany, February 28, 2014 – Sandoz announced today it has received South Korean marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD, marking its first approval in Asia.

The product was first approved in Denmark on December 18th, 2013, with subsequent approvals in Germany, Belgium, Sweden, Norway, Hungary, Romania and Bulgaria.

“We are pleased to receive the marketing authorization in South Korea for AirFluSal® Forspiro®. This is our first approval in Asia and outside Europe and a milestone in …

Munich, Germany, February 28, 2014 – Sandoz announced today it has received South Korean marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD, marking its first approval in Asia.

The product was first approved in Denmark on December 18th, 2013, with subsequent approvals in Germany, Belgium, Sweden, Norway, Hungary, Romania and Bulgaria.

“We are pleased to receive the marketing authorization in South Korea for AirFluSal® Forspiro®. This is our first approval in Asia and outside Europe and a milestone in …

March 7, 2014

Today Sandoz recognizes International Women’s Day (IWD), a globally-recognized day which celebrates the economic, social and cultural contributions made by women.

It is observed each year on March 8th. The United Nations theme for IWD this year is “Equality for Women is Progress for All.”

March 7, 2014

Today Sandoz recognizes International Women’s Day (IWD), a globally-recognized day which celebrates the economic, social and cultural contributions made by women.

It is observed each year on March 8th. The United Nations theme for IWD this year is “Equality for Women is Progress for All.”

March 14, 2014 – Sandoz 1 A Pharma is pleased to participate in the develoPPP.de (DPP) project “Quality Assured Essential Medicines for Ghana,” a three-year development partnership aimed at increasing access to high-quality, affordable medicines for patients in Ghana.

The project will be led by the German International Cooperation Agency, Deutsche Gesellschaft fuer Internationale Zummenarbeit GmbH (GIZ) and financed by the German Federal Ministry for Economic Cooperation and Development (BMZ).

The DPP project will focus on increasing access to medicines …